This new Trifocal IOL, was just approved for use in the United States on August 28th, 2019. It is the first trifocal lens approved in the U.S. Only select surgeons are approve to implant this new high tech IOL. Dr. Joseph is one of these select surgeons and is offering thing new cutting edge technology now!
Recommend AcrySof® IQ ReSTOR® +2.5 D IOL with ACTIVEFOCUSTM optical design for your patients with active lifestyles,* such as those who:
The ACTIVEFOCUSTOM optical design is engineered to take your patients' distance vision a step further while providing the balanced near and intermediate performance with the goal of reducing spectacle dependence for activities like1-3:
he proven performance of AcrySof® IQ Toric IOLs provides cataract treatment and astigmatism correction in a single procedure. Featuring exceptional rotational stability and a wide range of correction, AcrySof® IQ Toric IOLs can give your patients crisp, clear distance vision with reduced dependence on glasses.